Clinical Trial Update: Prophylactic Use of Milrinone After Congenital Heart Surgery in Infants [Phase 3]

View source ↗

Summary

This is a Phase 3 clinical trial update evaluating prophylactic milrinone to prevent low cardiac output syndrome after congenital heart surgery in infants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease
• Low Cardiac Output Syndrome

Drugs mentioned

• Milrinone (milrinone)

Snippet

Sponsor: Shanghai Children's Medical Center | Conditions: Low Cardiac Output Syndrome, Cardiac Surgical Procedures | Phase 3 | Status: UNKNOWN